CRBP
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 19 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 10, 2026.
Insiders have net sold $466K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Yuval Cohen
- Employees:36
- HQ:Norwood, MA, US
- IPO:2014-10-27
Insider Buying
$101K
reported purchases (SEC code P)
Insider Selling
$613K
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$188.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Cohen YuvalFirst in 6 months | Chief Executive Officer | Sale | 17,000 | $171K | Aug 10 | SEC ↗ |
Moran Sean F.First in 6 months | Chief Financial Officer | Sale | 12,000 | $121K | Aug 10 | SEC ↗ |
Kung WinstonFirst filing | Director | Sale | 2,026 | $16K | Jun 11 | SEC ↗ |
Altmeyer AnneFirst filing | Director | Sale | 2,412 | $19K | Jun 11 | SEC ↗ |
Jenkins John KennethFirst filing | Director | Sale | 4,800 | $38K | Jun 11 | SEC ↗ |
Saxena Nishant CFirst filing | Chief Business Officer | Purchase | 4,500 | $33K | Jun 3 | SEC ↗ |
Saxena Nishant CFirst filing | Chief Business Officer | Purchase | 9,000 | $68K | Jun 3 | SEC ↗ |
| Chief Medical Officer | Sale | 6,097 | $51K | Mar 4 | SEC ↗ | |
Moran Sean F.First filing | Chief Financial Officer | Sale | 4,701 | $37K | Feb 18 | SEC ↗ |
Cohen YuvalFirst filing | Chief Executive Officer | Sale | 13,871 | $108K | Feb 18 | SEC ↗ |
| Chief Operating Officer | Sale | 847 | $6K | Feb 18 | SEC ↗ | |
Smethurst DominicFirst filing | Chief Medical Officer | Sale | 3,285 | $27K | Feb 4 | SEC ↗ |
Hodgson IanFirst filing | Chief Operating Officer | Sale | 2,415 | $20K | Feb 4 | SEC ↗ |
Related companies
Corbus Pharmaceuticals Holdings, Inc. is in the Healthcare sector.